Despite no apparent link between iron overload and ferroptosis, substantial attention is warranted to investigate the possibility of ferroptosis during iron overload
A properly dosed GLP-1 might bring these down to 115 mg/dL (6.4 mmol/L) pre-meal and 160 mg/dL (8.9 mmol/L) after meals within 8-12 weeks
A., Boyko, E
Beyond their established role in T2D, GLP-1RAs are under investigation for potential therapeutic applications in additional clinical domains: non-alcoholic fatty liver disease (NAFLD) [22], neurodegenerative conditions [23], and addiction reduction(including smoking, alcohol use disorder, and cocaine use disorder, putatively via mechanisms analogous to those underlying appetite suppression) [23]
Medical Director for UK & USMedExpress In this interview, News Medical speaks with Dr Bryony Henderson , Medical Director for the UK and US at MedExpress , about the evolving role of GLP1 agonists in obesity care and the future of metabolic health treatments